nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2C9—brain cancer	0.479	1	CbGaD
Etoricoxib—CYP2D6—Lomustine—brain cancer	0.0547	0.171	CbGbCtD
Etoricoxib—CYP1A2—Carmustine—brain cancer	0.0541	0.169	CbGbCtD
Etoricoxib—PTGS2—Etoposide—brain cancer	0.0425	0.133	CbGbCtD
Etoricoxib—CYP2D6—Hydroxyurea—brain cancer	0.0414	0.129	CbGbCtD
Etoricoxib—CYP3A4—Temozolomide—brain cancer	0.0409	0.128	CbGbCtD
Etoricoxib—CYP3A4—Lomustine—brain cancer	0.0348	0.108	CbGbCtD
Etoricoxib—CYP2E1—Etoposide—brain cancer	0.0277	0.0865	CbGbCtD
Etoricoxib—CYP1A2—Etoposide—brain cancer	0.016	0.05	CbGbCtD
Etoricoxib—CYP3A4—Etoposide—brain cancer	0.0084	0.0262	CbGbCtD
Etoricoxib—Vismodegib—SHH—brain cancer	0.00378	0.516	CrCbGaD
Etoricoxib—Vismodegib—SMO—brain cancer	0.00217	0.297	CrCbGaD
Etoricoxib—MAPK14—blood vessel—brain cancer	0.00172	0.114	CbGeAlD
Etoricoxib—MAPK14—hindbrain—brain cancer	0.00164	0.109	CbGeAlD
Etoricoxib—MAPK14—brainstem—brain cancer	0.000939	0.0624	CbGeAlD
Etoricoxib—MAPK14—telencephalon—brain cancer	0.000833	0.0553	CbGeAlD
Etoricoxib—Celecoxib—CYP2C9—brain cancer	0.000738	0.101	CrCbGaD
Etoricoxib—MAPK14—pituitary gland—brain cancer	0.000678	0.0451	CbGeAlD
Etoricoxib—Vismodegib—CYP2C9—brain cancer	0.000633	0.0864	CrCbGaD
Etoricoxib—MAPK14—spinal cord—brain cancer	0.000584	0.0388	CbGeAlD
Etoricoxib—PTGS2—endothelium—brain cancer	0.000535	0.0356	CbGeAlD
Etoricoxib—MAPK14—endocrine gland—brain cancer	0.000525	0.0349	CbGeAlD
Etoricoxib—MAPK14—head—brain cancer	0.000519	0.0345	CbGeAlD
Etoricoxib—PTGS2—blood vessel—brain cancer	0.000494	0.0328	CbGeAlD
Etoricoxib—MAPK14—central nervous system—brain cancer	0.000474	0.0315	CbGeAlD
Etoricoxib—MAPK14—cerebellum—brain cancer	0.000463	0.0307	CbGeAlD
Etoricoxib—CYP2D6—hindbrain—brain cancer	0.000405	0.0269	CbGeAlD
Etoricoxib—MAPK14—brain—brain cancer	0.000376	0.025	CbGeAlD
Etoricoxib—Oedema—Procarbazine—brain cancer	0.000278	0.00245	CcSEcCtD
Etoricoxib—Infection—Procarbazine—brain cancer	0.000276	0.00244	CcSEcCtD
Etoricoxib—Hyperglycaemia—Carmustine—brain cancer	0.000276	0.00244	CcSEcCtD
Etoricoxib—Angiopathy—Hydroxyurea—brain cancer	0.000275	0.00243	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Temozolomide—brain cancer	0.000275	0.00243	CcSEcCtD
Etoricoxib—Pneumonia—Carmustine—brain cancer	0.000275	0.00242	CcSEcCtD
Etoricoxib—Shock—Procarbazine—brain cancer	0.000274	0.00242	CcSEcCtD
Etoricoxib—Thrombocytopenia—Procarbazine—brain cancer	0.000272	0.0024	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Temozolomide—brain cancer	0.00027	0.00238	CcSEcCtD
Etoricoxib—Weight increased—Temozolomide—brain cancer	0.000269	0.00238	CcSEcCtD
Etoricoxib—Renal failure—Carmustine—brain cancer	0.000268	0.00237	CcSEcCtD
Etoricoxib—Alopecia—Hydroxyurea—brain cancer	0.000268	0.00236	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Carmustine—brain cancer	0.000268	0.00236	CcSEcCtD
Etoricoxib—Hyperglycaemia—Temozolomide—brain cancer	0.000267	0.00235	CcSEcCtD
Etoricoxib—Stomatitis—Carmustine—brain cancer	0.000266	0.00235	CcSEcCtD
Etoricoxib—Urinary tract infection—Carmustine—brain cancer	0.000265	0.00234	CcSEcCtD
Etoricoxib—Pneumonia—Temozolomide—brain cancer	0.000265	0.00234	CcSEcCtD
Etoricoxib—Anorexia—Procarbazine—brain cancer	0.000265	0.00234	CcSEcCtD
Etoricoxib—Erythema—Hydroxyurea—brain cancer	0.000264	0.00233	CcSEcCtD
Etoricoxib—Infestation—Temozolomide—brain cancer	0.000264	0.00233	CcSEcCtD
Etoricoxib—Infestation NOS—Temozolomide—brain cancer	0.000264	0.00233	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000261	0.00231	CcSEcCtD
Etoricoxib—Cardiac arrest—Etoposide—brain cancer	0.00026	0.0023	CcSEcCtD
Etoricoxib—Nausea—Lomustine—brain cancer	0.00026	0.0023	CcSEcCtD
Etoricoxib—CYP2E1—telencephalon—brain cancer	0.00026	0.0173	CbGeAlD
Etoricoxib—Neuropathy peripheral—Temozolomide—brain cancer	0.000259	0.00228	CcSEcCtD
Etoricoxib—Stomatitis—Temozolomide—brain cancer	0.000257	0.00227	CcSEcCtD
Etoricoxib—Urinary tract infection—Temozolomide—brain cancer	0.000256	0.00226	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000253	0.00224	CcSEcCtD
Etoricoxib—Insomnia—Procarbazine—brain cancer	0.000252	0.00222	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Temozolomide—brain cancer	0.000249	0.0022	CcSEcCtD
Etoricoxib—Sinusitis—Temozolomide—brain cancer	0.000247	0.00218	CcSEcCtD
Etoricoxib—Somnolence—Procarbazine—brain cancer	0.000247	0.00218	CcSEcCtD
Etoricoxib—Cramp muscle—Etoposide—brain cancer	0.000247	0.00218	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000247	0.00218	CcSEcCtD
Etoricoxib—Haemoglobin—Carmustine—brain cancer	0.000246	0.00217	CcSEcCtD
Etoricoxib—Haemorrhage—Carmustine—brain cancer	0.000245	0.00216	CcSEcCtD
Etoricoxib—Anaemia—Hydroxyurea—brain cancer	0.000244	0.00215	CcSEcCtD
Etoricoxib—Hallucination—Carmustine—brain cancer	0.000244	0.00215	CcSEcCtD
Etoricoxib—Hypoaesthesia—Carmustine—brain cancer	0.000244	0.00215	CcSEcCtD
Etoricoxib—Decreased appetite—Procarbazine—brain cancer	0.000242	0.00213	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Etoposide—brain cancer	0.000242	0.00213	CcSEcCtD
Etoricoxib—Oedema peripheral—Carmustine—brain cancer	0.000241	0.00213	CcSEcCtD
Etoricoxib—Connective tissue disorder—Carmustine—brain cancer	0.000241	0.00212	CcSEcCtD
Etoricoxib—Fatigue—Procarbazine—brain cancer	0.00024	0.00212	CcSEcCtD
Etoricoxib—PTGS2—telencephalon—brain cancer	0.00024	0.0159	CbGeAlD
Etoricoxib—Haemoglobin—Temozolomide—brain cancer	0.000238	0.0021	CcSEcCtD
Etoricoxib—Pain—Procarbazine—brain cancer	0.000238	0.0021	CcSEcCtD
Etoricoxib—Constipation—Procarbazine—brain cancer	0.000238	0.0021	CcSEcCtD
Etoricoxib—Haemorrhage—Temozolomide—brain cancer	0.000237	0.00209	CcSEcCtD
Etoricoxib—Hepatitis—Temozolomide—brain cancer	0.000237	0.00209	CcSEcCtD
Etoricoxib—Visual impairment—Carmustine—brain cancer	0.000236	0.00208	CcSEcCtD
Etoricoxib—Hypoaesthesia—Temozolomide—brain cancer	0.000236	0.00208	CcSEcCtD
Etoricoxib—Hallucination—Temozolomide—brain cancer	0.000236	0.00208	CcSEcCtD
Etoricoxib—Pharyngitis—Temozolomide—brain cancer	0.000235	0.00207	CcSEcCtD
Etoricoxib—Urinary tract disorder—Temozolomide—brain cancer	0.000234	0.00206	CcSEcCtD
Etoricoxib—Oedema peripheral—Temozolomide—brain cancer	0.000233	0.00206	CcSEcCtD
Etoricoxib—Bronchospasm—Etoposide—brain cancer	0.000233	0.00205	CcSEcCtD
Etoricoxib—Connective tissue disorder—Temozolomide—brain cancer	0.000233	0.00205	CcSEcCtD
Etoricoxib—CYP2D6—brainstem—brain cancer	0.000232	0.0154	CbGeAlD
Etoricoxib—Urethral disorder—Temozolomide—brain cancer	0.000232	0.00205	CcSEcCtD
Etoricoxib—Feeling abnormal—Procarbazine—brain cancer	0.000229	0.00202	CcSEcCtD
Etoricoxib—Eye disorder—Carmustine—brain cancer	0.000229	0.00202	CcSEcCtD
Etoricoxib—Visual impairment—Temozolomide—brain cancer	0.000228	0.00201	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Procarbazine—brain cancer	0.000228	0.00201	CcSEcCtD
Etoricoxib—Flushing—Carmustine—brain cancer	0.000227	0.00201	CcSEcCtD
Etoricoxib—Erythema multiforme—Temozolomide—brain cancer	0.000224	0.00198	CcSEcCtD
Etoricoxib—CYP2C19—endocrine gland—brain cancer	0.000223	0.0148	CbGeAlD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000223	0.00197	CcSEcCtD
Etoricoxib—Eye disorder—Temozolomide—brain cancer	0.000221	0.00195	CcSEcCtD
Etoricoxib—Urticaria—Procarbazine—brain cancer	0.000221	0.00195	CcSEcCtD
Etoricoxib—Tinnitus—Temozolomide—brain cancer	0.000221	0.00195	CcSEcCtD
Etoricoxib—Abdominal pain—Procarbazine—brain cancer	0.00022	0.00194	CcSEcCtD
Etoricoxib—Flushing—Temozolomide—brain cancer	0.00022	0.00194	CcSEcCtD
Etoricoxib—Cardiac disorder—Temozolomide—brain cancer	0.00022	0.00194	CcSEcCtD
Etoricoxib—Arrhythmia—Carmustine—brain cancer	0.000219	0.00193	CcSEcCtD
Etoricoxib—Alopecia—Carmustine—brain cancer	0.000217	0.00191	CcSEcCtD
Etoricoxib—Oedema—Hydroxyurea—brain cancer	0.000215	0.0019	CcSEcCtD
Etoricoxib—Angiopathy—Temozolomide—brain cancer	0.000215	0.0019	CcSEcCtD
Etoricoxib—Mental disorder—Carmustine—brain cancer	0.000215	0.00189	CcSEcCtD
Etoricoxib—Infection—Hydroxyurea—brain cancer	0.000214	0.00189	CcSEcCtD
Etoricoxib—Immune system disorder—Temozolomide—brain cancer	0.000214	0.00189	CcSEcCtD
Etoricoxib—Mediastinal disorder—Temozolomide—brain cancer	0.000213	0.00188	CcSEcCtD
Etoricoxib—Malnutrition—Carmustine—brain cancer	0.000213	0.00188	CcSEcCtD
Etoricoxib—Erythema—Carmustine—brain cancer	0.000213	0.00188	CcSEcCtD
Etoricoxib—Pneumonia—Etoposide—brain cancer	0.000212	0.00187	CcSEcCtD
Etoricoxib—Nervous system disorder—Hydroxyurea—brain cancer	0.000211	0.00186	CcSEcCtD
Etoricoxib—Infestation NOS—Etoposide—brain cancer	0.000211	0.00186	CcSEcCtD
Etoricoxib—Infestation—Etoposide—brain cancer	0.000211	0.00186	CcSEcCtD
Etoricoxib—Thrombocytopenia—Hydroxyurea—brain cancer	0.000211	0.00186	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000209	0.00185	CcSEcCtD
Etoricoxib—Alopecia—Temozolomide—brain cancer	0.000209	0.00185	CcSEcCtD
Etoricoxib—Skin disorder—Hydroxyurea—brain cancer	0.000209	0.00185	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Etoposide—brain cancer	0.000208	0.00184	CcSEcCtD
Etoricoxib—Renal failure—Etoposide—brain cancer	0.000207	0.00183	CcSEcCtD
Etoricoxib—Mental disorder—Temozolomide—brain cancer	0.000207	0.00183	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Etoposide—brain cancer	0.000207	0.00183	CcSEcCtD
Etoricoxib—Myocardial infarction—Etoposide—brain cancer	0.000207	0.00183	CcSEcCtD
Etoricoxib—Erythema—Temozolomide—brain cancer	0.000206	0.00182	CcSEcCtD
Etoricoxib—Malnutrition—Temozolomide—brain cancer	0.000206	0.00182	CcSEcCtD
Etoricoxib—CYP2D6—telencephalon—brain cancer	0.000206	0.0137	CbGeAlD
Etoricoxib—Stomatitis—Etoposide—brain cancer	0.000206	0.00182	CcSEcCtD
Etoricoxib—Jaundice—Etoposide—brain cancer	0.000206	0.00182	CcSEcCtD
Etoricoxib—Anorexia—Hydroxyurea—brain cancer	0.000205	0.00181	CcSEcCtD
Etoricoxib—Hypersensitivity—Procarbazine—brain cancer	0.000205	0.00181	CcSEcCtD
Etoricoxib—CYP2E1—medulla oblongata—brain cancer	0.000204	0.0136	CbGeAlD
Etoricoxib—Dysgeusia—Temozolomide—brain cancer	0.000202	0.00178	CcSEcCtD
Etoricoxib—Vision blurred—Carmustine—brain cancer	0.000201	0.00177	CcSEcCtD
Etoricoxib—Tremor—Carmustine—brain cancer	0.0002	0.00176	CcSEcCtD
Etoricoxib—Asthenia—Procarbazine—brain cancer	0.0002	0.00176	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Etoposide—brain cancer	0.0002	0.00176	CcSEcCtD
Etoricoxib—Anaemia—Carmustine—brain cancer	0.000197	0.00174	CcSEcCtD
Etoricoxib—Pruritus—Procarbazine—brain cancer	0.000197	0.00174	CcSEcCtD
Etoricoxib—Agitation—Carmustine—brain cancer	0.000196	0.00173	CcSEcCtD
Etoricoxib—PTGS2—pituitary gland—brain cancer	0.000195	0.013	CbGeAlD
Etoricoxib—Vision blurred—Temozolomide—brain cancer	0.000194	0.00171	CcSEcCtD
Etoricoxib—Tremor—Temozolomide—brain cancer	0.000193	0.0017	CcSEcCtD
Etoricoxib—Dyspnoea—Hydroxyurea—brain cancer	0.000192	0.00169	CcSEcCtD
Etoricoxib—Somnolence—Hydroxyurea—brain cancer	0.000191	0.00169	CcSEcCtD
Etoricoxib—Anaemia—Temozolomide—brain cancer	0.000191	0.00168	CcSEcCtD
Etoricoxib—Diarrhoea—Procarbazine—brain cancer	0.00019	0.00168	CcSEcCtD
Etoricoxib—Dyspepsia—Hydroxyurea—brain cancer	0.00019	0.00167	CcSEcCtD
Etoricoxib—Agitation—Temozolomide—brain cancer	0.000189	0.00167	CcSEcCtD
Etoricoxib—Hypoaesthesia—Etoposide—brain cancer	0.000189	0.00166	CcSEcCtD
Etoricoxib—Angioedema—Temozolomide—brain cancer	0.000188	0.00166	CcSEcCtD
Etoricoxib—PTGS2—medulla oblongata—brain cancer	0.000188	0.0125	CbGeAlD
Etoricoxib—Decreased appetite—Hydroxyurea—brain cancer	0.000187	0.00165	CcSEcCtD
Etoricoxib—Urinary tract disorder—Etoposide—brain cancer	0.000187	0.00165	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000186	0.00164	CcSEcCtD
Etoricoxib—Urethral disorder—Etoposide—brain cancer	0.000186	0.00164	CcSEcCtD
Etoricoxib—Fatigue—Hydroxyurea—brain cancer	0.000186	0.00164	CcSEcCtD
Etoricoxib—Hypertension—Carmustine—brain cancer	0.000184	0.00162	CcSEcCtD
Etoricoxib—Constipation—Hydroxyurea—brain cancer	0.000184	0.00162	CcSEcCtD
Etoricoxib—Pain—Hydroxyurea—brain cancer	0.000184	0.00162	CcSEcCtD
Etoricoxib—Dizziness—Procarbazine—brain cancer	0.000184	0.00162	CcSEcCtD
Etoricoxib—CYP1A2—endocrine gland—brain cancer	0.000182	0.0121	CbGeAlD
Etoricoxib—CYP2E1—spinal cord—brain cancer	0.000182	0.0121	CbGeAlD
Etoricoxib—Palpitations—Temozolomide—brain cancer	0.000182	0.00161	CcSEcCtD
Etoricoxib—Chest pain—Carmustine—brain cancer	0.000182	0.0016	CcSEcCtD
Etoricoxib—Anxiety—Carmustine—brain cancer	0.000181	0.0016	CcSEcCtD
Etoricoxib—Cough—Temozolomide—brain cancer	0.00018	0.00159	CcSEcCtD
Etoricoxib—Erythema multiforme—Etoposide—brain cancer	0.000179	0.00158	CcSEcCtD
Etoricoxib—Hypertension—Temozolomide—brain cancer	0.000178	0.00157	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydroxyurea—brain cancer	0.000177	0.00157	CcSEcCtD
Etoricoxib—Eye disorder—Etoposide—brain cancer	0.000177	0.00156	CcSEcCtD
Etoricoxib—Vomiting—Procarbazine—brain cancer	0.000177	0.00156	CcSEcCtD
Etoricoxib—Flushing—Etoposide—brain cancer	0.000176	0.00155	CcSEcCtD
Etoricoxib—Cardiac disorder—Etoposide—brain cancer	0.000176	0.00155	CcSEcCtD
Etoricoxib—Confusional state—Carmustine—brain cancer	0.000176	0.00155	CcSEcCtD
Etoricoxib—Arthralgia—Temozolomide—brain cancer	0.000175	0.00155	CcSEcCtD
Etoricoxib—Rash—Procarbazine—brain cancer	0.000175	0.00155	CcSEcCtD
Etoricoxib—Dermatitis—Procarbazine—brain cancer	0.000175	0.00155	CcSEcCtD
Etoricoxib—Anxiety—Temozolomide—brain cancer	0.000175	0.00154	CcSEcCtD
Etoricoxib—Headache—Procarbazine—brain cancer	0.000174	0.00154	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000174	0.00154	CcSEcCtD
Etoricoxib—Oedema—Carmustine—brain cancer	0.000174	0.00154	CcSEcCtD
Etoricoxib—CYP2C9—endocrine gland—brain cancer	0.000173	0.0115	CbGeAlD
Etoricoxib—Infection—Carmustine—brain cancer	0.000173	0.00153	CcSEcCtD
Etoricoxib—PTGS2—midbrain—brain cancer	0.000172	0.0114	CbGeAlD
Etoricoxib—Angiopathy—Etoposide—brain cancer	0.000172	0.00152	CcSEcCtD
Etoricoxib—Dry mouth—Temozolomide—brain cancer	0.000172	0.00151	CcSEcCtD
Etoricoxib—Immune system disorder—Etoposide—brain cancer	0.000171	0.00151	CcSEcCtD
Etoricoxib—Mediastinal disorder—Etoposide—brain cancer	0.000171	0.00151	CcSEcCtD
Etoricoxib—Thrombocytopenia—Carmustine—brain cancer	0.00017	0.0015	CcSEcCtD
Etoricoxib—Confusional state—Temozolomide—brain cancer	0.00017	0.0015	CcSEcCtD
Etoricoxib—Anaphylactic shock—Temozolomide—brain cancer	0.000168	0.00148	CcSEcCtD
Etoricoxib—Oedema—Temozolomide—brain cancer	0.000168	0.00148	CcSEcCtD
Etoricoxib—PTGS2—spinal cord—brain cancer	0.000168	0.0112	CbGeAlD
Etoricoxib—Alopecia—Etoposide—brain cancer	0.000167	0.00148	CcSEcCtD
Etoricoxib—Infection—Temozolomide—brain cancer	0.000167	0.00147	CcSEcCtD
Etoricoxib—Anorexia—Carmustine—brain cancer	0.000166	0.00146	CcSEcCtD
Etoricoxib—Nausea—Procarbazine—brain cancer	0.000165	0.00146	CcSEcCtD
Etoricoxib—Nervous system disorder—Temozolomide—brain cancer	0.000165	0.00146	CcSEcCtD
Etoricoxib—Thrombocytopenia—Temozolomide—brain cancer	0.000165	0.00145	CcSEcCtD
Etoricoxib—CYP2E1—endocrine gland—brain cancer	0.000164	0.0109	CbGeAlD
Etoricoxib—Skin disorder—Temozolomide—brain cancer	0.000163	0.00144	CcSEcCtD
Etoricoxib—CYP2E1—head—brain cancer	0.000162	0.0108	CbGeAlD
Etoricoxib—Dysgeusia—Etoposide—brain cancer	0.000162	0.00143	CcSEcCtD
Etoricoxib—Anorexia—Temozolomide—brain cancer	0.00016	0.00141	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydroxyurea—brain cancer	0.000159	0.0014	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Carmustine—brain cancer	0.000159	0.0014	CcSEcCtD
Etoricoxib—Muscle spasms—Etoposide—brain cancer	0.000159	0.0014	CcSEcCtD
Etoricoxib—Insomnia—Carmustine—brain cancer	0.000157	0.00139	CcSEcCtD
Etoricoxib—Dyspnoea—Carmustine—brain cancer	0.000155	0.00137	CcSEcCtD
Etoricoxib—Somnolence—Carmustine—brain cancer	0.000155	0.00137	CcSEcCtD
Etoricoxib—Asthenia—Hydroxyurea—brain cancer	0.000154	0.00136	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000153	0.00135	CcSEcCtD
Etoricoxib—Anaemia—Etoposide—brain cancer	0.000152	0.00135	CcSEcCtD
Etoricoxib—Insomnia—Temozolomide—brain cancer	0.000152	0.00134	CcSEcCtD
Etoricoxib—Decreased appetite—Carmustine—brain cancer	0.000151	0.00134	CcSEcCtD
Etoricoxib—PTGS2—endocrine gland—brain cancer	0.000151	0.01	CbGeAlD
Etoricoxib—Gastrointestinal disorder—Carmustine—brain cancer	0.00015	0.00133	CcSEcCtD
Etoricoxib—Dyspnoea—Temozolomide—brain cancer	0.00015	0.00132	CcSEcCtD
Etoricoxib—Somnolence—Temozolomide—brain cancer	0.00015	0.00132	CcSEcCtD
Etoricoxib—PTGS2—head—brain cancer	0.000149	0.00991	CbGeAlD
Etoricoxib—Pain—Carmustine—brain cancer	0.000149	0.00131	CcSEcCtD
Etoricoxib—Constipation—Carmustine—brain cancer	0.000149	0.00131	CcSEcCtD
Etoricoxib—Dyspepsia—Temozolomide—brain cancer	0.000148	0.00131	CcSEcCtD
Etoricoxib—CYP2E1—central nervous system—brain cancer	0.000148	0.00982	CbGeAlD
Etoricoxib—Diarrhoea—Hydroxyurea—brain cancer	0.000147	0.0013	CcSEcCtD
Etoricoxib—Decreased appetite—Temozolomide—brain cancer	0.000146	0.00129	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Temozolomide—brain cancer	0.000145	0.00128	CcSEcCtD
Etoricoxib—Fatigue—Temozolomide—brain cancer	0.000145	0.00128	CcSEcCtD
Etoricoxib—CYP2E1—cerebellum—brain cancer	0.000145	0.0096	CbGeAlD
Etoricoxib—Cough—Etoposide—brain cancer	0.000144	0.00127	CcSEcCtD
Etoricoxib—Constipation—Temozolomide—brain cancer	0.000144	0.00127	CcSEcCtD
Etoricoxib—Pain—Temozolomide—brain cancer	0.000144	0.00127	CcSEcCtD
Etoricoxib—Feeling abnormal—Carmustine—brain cancer	0.000143	0.00127	CcSEcCtD
Etoricoxib—Hypertension—Etoposide—brain cancer	0.000142	0.00126	CcSEcCtD
Etoricoxib—Dizziness—Hydroxyurea—brain cancer	0.000142	0.00126	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Carmustine—brain cancer	0.000142	0.00126	CcSEcCtD
Etoricoxib—Chest pain—Etoposide—brain cancer	0.00014	0.00124	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000139	0.00123	CcSEcCtD
Etoricoxib—Feeling abnormal—Temozolomide—brain cancer	0.000139	0.00122	CcSEcCtD
Etoricoxib—Abdominal pain—Carmustine—brain cancer	0.000138	0.00121	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Temozolomide—brain cancer	0.000138	0.00121	CcSEcCtD
Etoricoxib—Vomiting—Hydroxyurea—brain cancer	0.000137	0.00121	CcSEcCtD
Etoricoxib—PTGS2—central nervous system—brain cancer	0.000136	0.00905	CbGeAlD
Etoricoxib—Rash—Hydroxyurea—brain cancer	0.000136	0.0012	CcSEcCtD
Etoricoxib—Confusional state—Etoposide—brain cancer	0.000136	0.0012	CcSEcCtD
Etoricoxib—Dermatitis—Hydroxyurea—brain cancer	0.000136	0.0012	CcSEcCtD
Etoricoxib—Headache—Hydroxyurea—brain cancer	0.000135	0.00119	CcSEcCtD
Etoricoxib—Anaphylactic shock—Etoposide—brain cancer	0.000135	0.00119	CcSEcCtD
Etoricoxib—Infection—Etoposide—brain cancer	0.000134	0.00118	CcSEcCtD
Etoricoxib—Urticaria—Temozolomide—brain cancer	0.000134	0.00118	CcSEcCtD
Etoricoxib—PTGS2—cerebellum—brain cancer	0.000133	0.00884	CbGeAlD
Etoricoxib—Abdominal pain—Temozolomide—brain cancer	0.000133	0.00117	CcSEcCtD
Etoricoxib—CYP3A4—endocrine gland—brain cancer	0.000132	0.00877	CbGeAlD
Etoricoxib—Thrombocytopenia—Etoposide—brain cancer	0.000132	0.00116	CcSEcCtD
Etoricoxib—Skin disorder—Etoposide—brain cancer	0.000131	0.00115	CcSEcCtD
Etoricoxib—CYP2D6—endocrine gland—brain cancer	0.00013	0.00863	CbGeAlD
Etoricoxib—Anorexia—Etoposide—brain cancer	0.000128	0.00113	CcSEcCtD
Etoricoxib—CYP2D6—head—brain cancer	0.000128	0.00852	CbGeAlD
Etoricoxib—Hypersensitivity—Carmustine—brain cancer	0.000128	0.00113	CcSEcCtD
Etoricoxib—Nausea—Hydroxyurea—brain cancer	0.000128	0.00113	CcSEcCtD
Etoricoxib—Asthenia—Carmustine—brain cancer	0.000125	0.0011	CcSEcCtD
Etoricoxib—Hypersensitivity—Temozolomide—brain cancer	0.000124	0.00109	CcSEcCtD
Etoricoxib—Asthenia—Temozolomide—brain cancer	0.000121	0.00106	CcSEcCtD
Etoricoxib—Dyspnoea—Etoposide—brain cancer	0.00012	0.00106	CcSEcCtD
Etoricoxib—Somnolence—Etoposide—brain cancer	0.00012	0.00106	CcSEcCtD
Etoricoxib—Diarrhoea—Carmustine—brain cancer	0.000119	0.00105	CcSEcCtD
Etoricoxib—Pruritus—Temozolomide—brain cancer	0.000119	0.00105	CcSEcCtD
Etoricoxib—CYP3A4—central nervous system—brain cancer	0.000119	0.00791	CbGeAlD
Etoricoxib—CYP2E1—brain—brain cancer	0.000117	0.0078	CbGeAlD
Etoricoxib—CYP2D6—central nervous system—brain cancer	0.000117	0.00778	CbGeAlD
Etoricoxib—Decreased appetite—Etoposide—brain cancer	0.000117	0.00103	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Etoposide—brain cancer	0.000116	0.00103	CcSEcCtD
Etoricoxib—Fatigue—Etoposide—brain cancer	0.000116	0.00102	CcSEcCtD
Etoricoxib—Dizziness—Carmustine—brain cancer	0.000115	0.00102	CcSEcCtD
Etoricoxib—Constipation—Etoposide—brain cancer	0.000115	0.00102	CcSEcCtD
Etoricoxib—Pain—Etoposide—brain cancer	0.000115	0.00102	CcSEcCtD
Etoricoxib—Diarrhoea—Temozolomide—brain cancer	0.000115	0.00102	CcSEcCtD
Etoricoxib—CYP2D6—cerebellum—brain cancer	0.000114	0.0076	CbGeAlD
Etoricoxib—Dizziness—Temozolomide—brain cancer	0.000111	0.000981	CcSEcCtD
Etoricoxib—Feeling abnormal—Etoposide—brain cancer	0.000111	0.000979	CcSEcCtD
Etoricoxib—Vomiting—Carmustine—brain cancer	0.000111	0.000977	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Etoposide—brain cancer	0.00011	0.000971	CcSEcCtD
Etoricoxib—Rash—Carmustine—brain cancer	0.00011	0.000968	CcSEcCtD
Etoricoxib—Dermatitis—Carmustine—brain cancer	0.00011	0.000967	CcSEcCtD
Etoricoxib—Headache—Carmustine—brain cancer	0.000109	0.000962	CcSEcCtD
Etoricoxib—PTGS2—brain—brain cancer	0.000108	0.00718	CbGeAlD
Etoricoxib—Vomiting—Temozolomide—brain cancer	0.000107	0.000944	CcSEcCtD
Etoricoxib—Urticaria—Etoposide—brain cancer	0.000107	0.000944	CcSEcCtD
Etoricoxib—Abdominal pain—Etoposide—brain cancer	0.000106	0.000939	CcSEcCtD
Etoricoxib—Rash—Temozolomide—brain cancer	0.000106	0.000936	CcSEcCtD
Etoricoxib—Dermatitis—Temozolomide—brain cancer	0.000106	0.000935	CcSEcCtD
Etoricoxib—Headache—Temozolomide—brain cancer	0.000105	0.00093	CcSEcCtD
Etoricoxib—Nausea—Carmustine—brain cancer	0.000103	0.000912	CcSEcCtD
Etoricoxib—Nausea—Temozolomide—brain cancer	9.99e-05	0.000882	CcSEcCtD
Etoricoxib—Hypersensitivity—Etoposide—brain cancer	9.92e-05	0.000875	CcSEcCtD
Etoricoxib—Asthenia—Etoposide—brain cancer	9.66e-05	0.000852	CcSEcCtD
Etoricoxib—Pruritus—Etoposide—brain cancer	9.52e-05	0.00084	CcSEcCtD
Etoricoxib—CYP2D6—brain—brain cancer	9.3e-05	0.00618	CbGeAlD
Etoricoxib—Diarrhoea—Etoposide—brain cancer	9.21e-05	0.000813	CcSEcCtD
Etoricoxib—Dizziness—Etoposide—brain cancer	8.9e-05	0.000785	CcSEcCtD
Etoricoxib—MAPK14—TSH signaling pathway—MYC—brain cancer	8.67e-05	0.00133	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—MYC—brain cancer	8.57e-05	0.00132	CbGpPWpGaD
Etoricoxib—Vomiting—Etoposide—brain cancer	8.56e-05	0.000755	CcSEcCtD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—IL2—brain cancer	8.5e-05	0.00131	CbGpPWpGaD
Etoricoxib—Rash—Etoposide—brain cancer	8.49e-05	0.000749	CcSEcCtD
Etoricoxib—MAPK14—AGE/RAGE pathway—EGFR—brain cancer	8.48e-05	0.00131	CbGpPWpGaD
Etoricoxib—Dermatitis—Etoposide—brain cancer	8.48e-05	0.000748	CcSEcCtD
Etoricoxib—MAPK14—BDNF signaling pathway—APC—brain cancer	8.44e-05	0.0013	CbGpPWpGaD
Etoricoxib—Headache—Etoposide—brain cancer	8.43e-05	0.000744	CcSEcCtD
Etoricoxib—MAPK14—Leptin signaling pathway—STAT3—brain cancer	8.42e-05	0.0013	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—EGFR—brain cancer	8.38e-05	0.00129	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.28e-05	0.00127	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CTNNB1—brain cancer	8.21e-05	0.00126	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—PDGFRA—brain cancer	8.18e-05	0.00126	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.04e-05	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—RELA—brain cancer	8.01e-05	0.00123	CbGpPWpGaD
Etoricoxib—Nausea—Etoposide—brain cancer	8e-05	0.000705	CcSEcCtD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—CDKN2A—brain cancer	7.98e-05	0.00123	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—TP53—brain cancer	7.79e-05	0.0012	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—PIK3CG—brain cancer	7.76e-05	0.00119	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.71e-05	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—STAT3—brain cancer	7.69e-05	0.00118	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—VAV1—brain cancer	7.68e-05	0.00118	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.6e-05	0.00117	CbGpPWpGaD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	7.56e-05	0.00116	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	7.53e-05	0.00116	CbGpPWpGaD
Etoricoxib—MAPK14—p73 transcription factor network—MYC—brain cancer	7.51e-05	0.00116	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	7.5e-05	0.00116	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	7.39e-05	0.00114	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDK4—brain cancer	7.31e-05	0.00112	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—SIRT1—brain cancer	7.3e-05	0.00112	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—CTNNB1—brain cancer	7.27e-05	0.00112	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.23e-05	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CCNE1—brain cancer	7.21e-05	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—brain cancer	7.21e-05	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IRS2—brain cancer	7.18e-05	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.15e-05	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—brain cancer	7.04e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—SOD2—brain cancer	7.03e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—OR4C12—brain cancer	6.88e-05	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—OR14C36—brain cancer	6.88e-05	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—CTNNB1—brain cancer	6.87e-05	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	6.79e-05	0.00104	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.78e-05	0.00104	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	6.74e-05	0.00104	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.73e-05	0.00104	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CDK4—brain cancer	6.72e-05	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—RELA—brain cancer	6.71e-05	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TRPC6—brain cancer	6.62e-05	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—RELA—brain cancer	6.6e-05	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TRPC6—brain cancer	6.49e-05	0.000999	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—VEGFA—brain cancer	6.4e-05	0.000986	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—MYC—brain cancer	6.37e-05	0.000981	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PDGFRA—brain cancer	6.29e-05	0.000968	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	6.25e-05	0.000962	CbGpPWpGaD
Etoricoxib—MAPK14—Cell-Cell communication—CTNNB1—brain cancer	6.22e-05	0.000958	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—CCND1—brain cancer	6.21e-05	0.000956	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.16e-05	0.000949	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—VEGFA—brain cancer	6.04e-05	0.00093	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.04e-05	0.00093	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	5.99e-05	0.000922	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—brain cancer	5.99e-05	0.000921	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.97e-05	0.000919	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	5.97e-05	0.000918	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.94e-05	0.000915	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—DTX2—brain cancer	5.85e-05	0.0009	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—CTNNB1—brain cancer	5.73e-05	0.000883	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	5.69e-05	0.000876	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDKN2A—brain cancer	5.59e-05	0.00086	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.55e-05	0.000854	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDK4—brain cancer	5.52e-05	0.00085	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IRS2—brain cancer	5.52e-05	0.00085	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—RELA—brain cancer	5.37e-05	0.000827	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.35e-05	0.000824	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—DTX2—brain cancer	5.33e-05	0.000821	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.29e-05	0.000814	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.23e-05	0.000805	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—STAT3—brain cancer	5e-05	0.000769	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—MYC—brain cancer	4.98e-05	0.000767	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.95e-05	0.000763	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	4.92e-05	0.000758	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.92e-05	0.000757	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—brain cancer	4.91e-05	0.000756	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VAV1—brain cancer	4.86e-05	0.000749	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.62e-05	0.000711	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.57e-05	0.000704	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.57e-05	0.000704	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—MYC—brain cancer	4.57e-05	0.000703	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—STAT3—brain cancer	4.55e-05	0.0007	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.55e-05	0.0007	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—brain cancer	4.45e-05	0.000685	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—brain cancer	4.44e-05	0.000684	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTCH2—brain cancer	4.43e-05	0.000682	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—VAV1—brain cancer	4.38e-05	0.000674	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CCND1—brain cancer	4.34e-05	0.000668	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.3e-05	0.000662	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HES5—brain cancer	4.29e-05	0.000661	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HES1—brain cancer	4.26e-05	0.000657	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN2A—brain cancer	4.22e-05	0.00065	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—brain cancer	4.22e-05	0.000649	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.18e-05	0.000644	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STRADA—brain cancer	4.17e-05	0.000641	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—brain cancer	4.13e-05	0.000636	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—MYC—brain cancer	4.11e-05	0.000632	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.09e-05	0.00063	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.09e-05	0.00063	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—brain cancer	4.09e-05	0.00063	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—STAT3—brain cancer	4.07e-05	0.000627	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—RELA—brain cancer	4.06e-05	0.000625	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.03e-05	0.00062	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—brain cancer	4.02e-05	0.000618	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HES5—brain cancer	3.92e-05	0.000603	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.83e-05	0.00059	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—RELA—brain cancer	3.81e-05	0.000586	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—ERBB2—brain cancer	3.79e-05	0.000583	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	3.75e-05	0.000578	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.71e-05	0.00057	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.62e-05	0.000558	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.6e-05	0.000554	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PDGFRA—brain cancer	3.59e-05	0.000552	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.58e-05	0.000552	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MYC—brain cancer	3.48e-05	0.000536	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ABR—brain cancer	3.48e-05	0.000535	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	3.41e-05	0.000525	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—brain cancer	3.4e-05	0.000524	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—brain cancer	3.37e-05	0.000519	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GLI2—brain cancer	3.36e-05	0.000517	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—SKP2—brain cancer	3.35e-05	0.000515	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CDK4—brain cancer	3.34e-05	0.000515	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.34e-05	0.000514	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.28e-05	0.000505	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GLI1—brain cancer	3.16e-05	0.000486	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IRS2—brain cancer	3.15e-05	0.000485	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—DNMT1—brain cancer	3.13e-05	0.000482	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—VEGFA—brain cancer	3.11e-05	0.000479	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—brain cancer	3.11e-05	0.000478	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PIK3CG—brain cancer	3.09e-05	0.000475	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—brain cancer	3.08e-05	0.000474	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.04e-05	0.000468	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP2C9—brain cancer	3.02e-05	0.000464	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SUFU—brain cancer	2.99e-05	0.000461	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.95e-05	0.000454	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.92e-05	0.00045	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GFAP—brain cancer	2.89e-05	0.000445	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—brain cancer	2.89e-05	0.000444	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—brain cancer	2.86e-05	0.00044	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP2C9—brain cancer	2.84e-05	0.000437	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR2—brain cancer	2.81e-05	0.000432	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.8e-05	0.000432	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HEY1—brain cancer	2.74e-05	0.000421	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—DLL1—brain cancer	2.68e-05	0.000413	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH2—brain cancer	2.66e-05	0.00041	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IDH1—brain cancer	2.63e-05	0.000406	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—brain cancer	2.62e-05	0.000404	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.57e-05	0.000396	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BSG—brain cancer	2.57e-05	0.000395	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—VAV1—brain cancer	2.55e-05	0.000393	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HEY1—brain cancer	2.5e-05	0.000384	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—RELA—brain cancer	2.46e-05	0.000379	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—DLL1—brain cancer	2.45e-05	0.000377	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—ERBB2—brain cancer	2.44e-05	0.000376	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BSG—brain cancer	2.42e-05	0.000372	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.37e-05	0.000364	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—brain cancer	2.35e-05	0.000362	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.32e-05	0.000356	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SHH—brain cancer	2.28e-05	0.000351	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SIRT1—brain cancer	2.26e-05	0.000348	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—IDH1—brain cancer	2.21e-05	0.00034	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TRPC6—brain cancer	2.2e-05	0.000339	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2C9—brain cancer	2.19e-05	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—brain cancer	2.17e-05	0.000335	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RELA—brain cancer	2.17e-05	0.000334	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMO—brain cancer	2.16e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTCH1—brain cancer	2.16e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—ERBB2—brain cancer	2.16e-05	0.000332	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CTNNB1—brain cancer	2.14e-05	0.000329	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PDGFRA—brain cancer	2.09e-05	0.000322	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SHH—brain cancer	2.08e-05	0.000321	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ENO2—brain cancer	2.08e-05	0.000321	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—IDH1—brain cancer	2.08e-05	0.00032	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP2C9—brain cancer	2.02e-05	0.00031	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.94e-05	0.000299	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CTNNB1—brain cancer	1.89e-05	0.000291	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—brain cancer	1.88e-05	0.00029	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—brain cancer	1.86e-05	0.000287	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BSG—brain cancer	1.86e-05	0.000287	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—brain cancer	1.85e-05	0.000284	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRS2—brain cancer	1.83e-05	0.000282	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.8e-05	0.000277	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ENO2—brain cancer	1.74e-05	0.000268	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH2—brain cancer	1.73e-05	0.000266	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BSG—brain cancer	1.71e-05	0.000264	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2C9—brain cancer	1.71e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BSG—brain cancer	1.7e-05	0.000262	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—brain cancer	1.69e-05	0.000261	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VAV1—brain cancer	1.65e-05	0.000254	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ENO2—brain cancer	1.64e-05	0.000253	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—IDH1—brain cancer	1.6e-05	0.000247	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—VAV1—brain cancer	1.5e-05	0.000232	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—brain cancer	1.5e-05	0.00023	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—IDH1—brain cancer	1.47e-05	0.000227	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—IDH1—brain cancer	1.46e-05	0.000225	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BSG—brain cancer	1.45e-05	0.000224	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HES1—brain cancer	1.42e-05	0.000218	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—brain cancer	1.4e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PDGFRA—brain cancer	1.35e-05	0.000208	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2C9—brain cancer	1.32e-05	0.000203	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SPP1—brain cancer	1.31e-05	0.000202	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.3e-05	0.000201	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HES1—brain cancer	1.29e-05	0.000199	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ENO2—brain cancer	1.27e-05	0.000195	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RELA—brain cancer	1.27e-05	0.000195	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ERBB2—brain cancer	1.26e-05	0.000194	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—IDH1—brain cancer	1.25e-05	0.000192	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PDGFRA—brain cancer	1.23e-05	0.00019	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.19e-05	0.000183	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IRS2—brain cancer	1.19e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ENO2—brain cancer	1.17e-05	0.000179	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ENO2—brain cancer	1.15e-05	0.000178	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—brain cancer	1.14e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BSG—brain cancer	1.12e-05	0.000172	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—brain cancer	1.1e-05	0.000169	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS2—brain cancer	1.08e-05	0.000167	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APC—brain cancer	1.05e-05	0.000161	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.02e-05	0.000156	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ENO2—brain cancer	9.87e-06	0.000152	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—IDH1—brain cancer	9.64e-06	0.000148	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—brain cancer	9.59e-06	0.000148	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APC—brain cancer	9.55e-06	0.000147	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—brain cancer	8.86e-06	0.000136	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—brain cancer	8.72e-06	0.000134	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—brain cancer	8.18e-06	0.000126	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB2—brain cancer	8.13e-06	0.000125	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CG—brain cancer	8e-06	0.000123	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO2—brain cancer	7.62e-06	0.000117	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CG—brain cancer	7.53e-06	0.000116	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB2—brain cancer	7.42e-06	0.000114	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—brain cancer	7.37e-06	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—brain cancer	7.18e-06	0.000111	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—brain cancer	7.11e-06	0.00011	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—brain cancer	6.49e-06	9.99e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—brain cancer	6.26e-06	9.64e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—brain cancer	6.2e-06	9.55e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CG—brain cancer	5.81e-06	8.94e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—brain cancer	5.76e-06	8.87e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—brain cancer	5.66e-06	8.71e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—brain cancer	5.64e-06	8.68e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CG—brain cancer	5.34e-06	8.23e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CG—brain cancer	5.3e-06	8.16e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—brain cancer	5.26e-06	8.09e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—brain cancer	5.14e-06	7.91e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—brain cancer	4.73e-06	7.28e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CG—brain cancer	4.53e-06	6.97e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CG—brain cancer	3.49e-06	5.38e-05	CbGpPWpGaD
